2. Characterisation of an AML-derived immunomodulatory factor(s) that inhibit T cell activation and the signal transduction pathways involved. American Society of Hematology meeting. San Francisco, USA,
- Pepper née Buggins, A. (Speaker)
Activity: Participating in or organising an event › Participation in conference